These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


476 related items for PubMed ID: 21567103

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
    Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, Wang Q, Shen X.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct 01; 877(27):3111-7. PubMed ID: 19716777
    [Abstract] [Full Text] [Related]

  • 5. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry.
    Yu L, Aa J, Xu J, Sun M, Qian S, Cheng L, Yang S, Shi R.
    J Gastroenterol Hepatol; 2011 Aug 01; 26(8):1290-7. PubMed ID: 21443661
    [Abstract] [Full Text] [Related]

  • 6. Serum metabolic profiling of human gastric cancer based on gas chromatography/mass spectrometry.
    Song H, Peng JS, Dong-Sheng Y, Yang ZL, Liu HL, Zeng YK, Shi XP, Lu BY.
    Braz J Med Biol Res; 2012 Jan 01; 45(1):78-85. PubMed ID: 22124703
    [Abstract] [Full Text] [Related]

  • 7. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.
    Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W.
    J Proteome Res; 2009 Oct 01; 8(10):4844-50. PubMed ID: 19678709
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
    Chen Y, Zhang R, Song Y, He J, Sun J, Bai J, An Z, Dong L, Zhan Q, Abliz Z.
    Analyst; 2009 Oct 01; 134(10):2003-11. PubMed ID: 19768207
    [Abstract] [Full Text] [Related]

  • 15. Tissue metabolic profiling of human gastric cancer assessed by (1)H NMR.
    Wang H, Zhang H, Deng P, Liu C, Li D, Jie H, Zhang H, Zhou Z, Zhao YL.
    BMC Cancer; 2016 Jun 29; 16():371. PubMed ID: 27356757
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers.
    Woo HM, Kim KM, Choi MH, Jung BH, Lee J, Kong G, Nam SJ, Kim S, Bai SW, Chung BC.
    Clin Chim Acta; 2009 Feb 29; 400(1-2):63-9. PubMed ID: 19010317
    [Abstract] [Full Text] [Related]

  • 19. Metabolomic study of the fever model induced by baker's yeast and the antipyretic effects of aspirin in rats using nuclear magnetic resonance and gas chromatography-mass spectrometry.
    Zhang F, Wang D, Li X, Li Z, Chao J, Qin X.
    J Pharm Biomed Anal; 2013 Feb 29; 81-82():168-77. PubMed ID: 23670098
    [Abstract] [Full Text] [Related]

  • 20. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
    Liang Q, Wang C, Li B.
    Appl Biochem Biotechnol; 2015 Aug 29; 176(8):2170-84. PubMed ID: 26088916
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.